Immunotherapy in chronic myelogenous leukemia.
Guilhot, François
Immunotherapy in chronic myelogenous leukemia. [electronic resource] - Clinical lymphoma & myeloma Mar 2007 - S64-70 p. digital
Publication Type: Journal Article; Review
1557-9190
10.3816/clm.2007.s.004 doi
Benzamides
Clinical Trials as Topic
Heat-Shock Proteins--immunology
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Immunotherapy--methods
Immunotherapy, Adoptive
Interferons--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy
Piperazines--therapeutic use
Pyrimidines--therapeutic use
T-Lymphocytes, Cytotoxic--immunology
Transplantation, Homologous
Immunotherapy in chronic myelogenous leukemia. [electronic resource] - Clinical lymphoma & myeloma Mar 2007 - S64-70 p. digital
Publication Type: Journal Article; Review
1557-9190
10.3816/clm.2007.s.004 doi
Benzamides
Clinical Trials as Topic
Heat-Shock Proteins--immunology
Hematopoietic Stem Cell Transplantation
Humans
Imatinib Mesylate
Immunotherapy--methods
Immunotherapy, Adoptive
Interferons--therapeutic use
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--therapy
Piperazines--therapeutic use
Pyrimidines--therapeutic use
T-Lymphocytes, Cytotoxic--immunology
Transplantation, Homologous